Klinicheskaya Onkogematologiya/Clinical Oncohematology最新文献

筛选
英文 中文
Immune checkpoint inhibitors in pediatric hematologic malignancies 免疫检查点抑制剂在儿童血液恶性肿瘤中的应用
Klinicheskaya Onkogematologiya/Clinical Oncohematology Pub Date : 2023-05-27 DOI: 10.17650/1818-8346-2023-18-2-25-34
I. Gribkova
{"title":"Immune checkpoint inhibitors in pediatric hematologic malignancies","authors":"I. Gribkova","doi":"10.17650/1818-8346-2023-18-2-25-34","DOIUrl":"https://doi.org/10.17650/1818-8346-2023-18-2-25-34","url":null,"abstract":"The use of immune checkpoint inhibitors as therapy in adult patients with malignancy has resulted in an improvement in overall survival. Research on the use of these drugs in pediatric oncology is just beginning. However, the results already obtained indicate the possibility of successful use of checkpoint inhibitors in children with Hodgkin’s lymphoma and some subtypes of non-Hodgkin’s lymphomas. This review analyzes the results of studies on the use of nivolumab and pembrolizumab for the treatment of children with lymphomas. The search for available literature sources was carried out in the databases PubMed, Scopus, eLibrary, Cyberleninka. The review also addresses the issue of possible predictors of response to immune checkpoint inhibitor therapy in children.","PeriodicalId":36905,"journal":{"name":"Klinicheskaya Onkogematologiya/Clinical Oncohematology","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90046370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expert Council Review “Multiple myeloma” 专家委员会评论“多发性骨髓瘤”
Klinicheskaya Onkogematologiya/Clinical Oncohematology Pub Date : 2023-05-26 DOI: 10.17650/1818-8346-2023-18-2-10-16
M. I. Akhmedov, P. A. Zeynalova
{"title":"Expert Council Review “Multiple myeloma”","authors":"M. I. Akhmedov, P. A. Zeynalova","doi":"10.17650/1818-8346-2023-18-2-10-16","DOIUrl":"https://doi.org/10.17650/1818-8346-2023-18-2-10-16","url":null,"abstract":"<jats:p>.</jats:p>","PeriodicalId":36905,"journal":{"name":"Klinicheskaya Onkogematologiya/Clinical Oncohematology","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82298688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of somatic mutations in the JAK2, CALR, MPL and ASXL1 genes and evaluation of their impact on the survival of patients with myelofibrosis JAK2、CALR、MPL和ASXL1基因体细胞突变分析及其对骨髓纤维化患者生存的影响
Klinicheskaya Onkogematologiya/Clinical Oncohematology Pub Date : 2023-03-15 DOI: 10.17650/1818-8346-2023-18-1-63-75
T. Subbotina, I. Maslyukova, K. S. Semashchenko, G. Khodos, D. Kurochkin, A. A. Shalyova, M. Mikhalev, E. V. Vasiliev, M. Osadchaya, E. Dunaeva, A. Esman, K. Mironov
{"title":"Analysis of somatic mutations in the JAK2, CALR, MPL and ASXL1 genes and evaluation of their impact on the survival of patients with myelofibrosis","authors":"T. Subbotina, I. Maslyukova, K. S. Semashchenko, G. Khodos, D. Kurochkin, A. A. Shalyova, M. Mikhalev, E. V. Vasiliev, M. Osadchaya, E. Dunaeva, A. Esman, K. Mironov","doi":"10.17650/1818-8346-2023-18-1-63-75","DOIUrl":"https://doi.org/10.17650/1818-8346-2023-18-1-63-75","url":null,"abstract":"Background. The development of myelofibrosis (MF) is driven by complex molecular genetic events that include driver somatic mutations responsible for the constitutive activation of the JAK/STAT signaling pathway (JAK2, CALR, and MPL), additional mutations affecting epigenetic regulators (TET2, ASXL1, IDH1/2, etc.) and RNA splicing (SRSF2, U2AF1, SF3B1, etc.), as well as genetic aberrations that contribute to genomic instability and disease progression.Aim. To analyze driver (JAK2, CALR, MPL) and prognostic (ASXL1) somatic mutations in patients with MF and evaluate their impact on survival.Materials and methods. The study included 29 patients diagnosed with MF, selected by hematologists from the City Clinical Hospital No. 7 and Regional Clinical Hospital (Krasnoyarsk).Results. 26 (89.6 %) out of 29 examined patients had some driver mutations in JAK2, CALR, MPL genes. The p.V617F mutation in the JAK2 gene was found in 20 (68.9 %) patients. Mutations in the CALR gene were detected in 4 (13.8 %) patients, mutations in the MPL gene were found in 3 patients (10.3 %). In 1 of 26 patients, 2 driver mutations were present simultaneously. 3 (10.3 %) patients were triple negative. Mutations in the ASXL1 gene were detected in 12 (41.4 %) out of 29 examined patients. Conducted targeted NGS (next generation sequencing) for 13 out of 29 patients revealed additional genetic variants that contribute to the understanding of the development mechanism and disease course. When evaluating the overall survival in the groups of patients diagnosed with MF examined by us, depending on the combination of driver (JAK2, CALR, MPL) and prognostic (ASXL1) mutations, no statistically significant differences were found (p = 0.12). This appears to be due to the small sample size. At the same time, assessment of patient survival depending on ASXL1 status showed that in the presence of mutations in the ASXL1 gene, the median survival was 45 months (range 7–120 months), while in the absence of mutations it was 48 months (range 21–359 months) (p = 0.03).Conclusion. The results obtained allow us to assume that the presence of mutations in the ASXL1 gene is an unfavorable factor in the course of the disease.","PeriodicalId":36905,"journal":{"name":"Klinicheskaya Onkogematologiya/Clinical Oncohematology","volume":"150 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86150354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasma cell dyscrasia: monoclonal gammopathies, AL-amyloidosis, multiple myeloma Clinical case study 浆细胞病变:单克隆伽玛病、al -淀粉样变性、多发性骨髓瘤临床病例研究
Klinicheskaya Onkogematologiya/Clinical Oncohematology Pub Date : 2023-03-15 DOI: 10.17650/1818-8346-2023-18-1-57-62
V. Cherepanova, M. A. Kurysheva, S. Odintsova
{"title":"Plasma cell dyscrasia: monoclonal gammopathies, AL-amyloidosis, multiple myeloma Clinical case study","authors":"V. Cherepanova, M. A. Kurysheva, S. Odintsova","doi":"10.17650/1818-8346-2023-18-1-57-62","DOIUrl":"https://doi.org/10.17650/1818-8346-2023-18-1-57-62","url":null,"abstract":"","PeriodicalId":36905,"journal":{"name":"Klinicheskaya Onkogematologiya/Clinical Oncohematology","volume":"39 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84403274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk of bloodstream infections in allogeneic hematopoietic cell transplant recipients according to gut mucosal colonization and fluoroquinolone implementation during neutropenia 根据中性粒细胞减少期间肠道黏膜定植和氟喹诺酮的实施,异基因造血细胞移植受者血流感染的风险
Klinicheskaya Onkogematologiya/Clinical Oncohematology Pub Date : 2023-03-15 DOI: 10.17650/1818-8346-2023-18-1-88-100
G. Klyasova, M. Akhmedov, L. Kuzmina, A. Fedorova, D. Mironova, E. Parovichnikova
{"title":"Risk of bloodstream infections in allogeneic hematopoietic cell transplant recipients according to gut mucosal colonization and fluoroquinolone implementation during neutropenia","authors":"G. Klyasova, M. Akhmedov, L. Kuzmina, A. Fedorova, D. Mironova, E. Parovichnikova","doi":"10.17650/1818-8346-2023-18-1-88-100","DOIUrl":"https://doi.org/10.17650/1818-8346-2023-18-1-88-100","url":null,"abstract":"","PeriodicalId":36905,"journal":{"name":"Klinicheskaya Onkogematologiya/Clinical Oncohematology","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73368961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative clinical and economic evaluation of polatuzumab vedotin in combination with rituximab, cyclophosphamide, doxorubicin and prednisolone (R-CHP) in the 1st line therapy for adult patients with diffuse large B-cell lymphoma polatuzumab vedotin联合利妥昔单抗、环磷酰胺、阿霉素和强的松龙(R-CHP)一线治疗成人弥漫性大b细胞淋巴瘤的临床和经济比较评价
Klinicheskaya Onkogematologiya/Clinical Oncohematology Pub Date : 2023-03-15 DOI: 10.17650/1818-8346-2023-18-1-76-87
I. Dyakov
{"title":"Comparative clinical and economic evaluation of polatuzumab vedotin in combination with rituximab, cyclophosphamide, doxorubicin and prednisolone (R-CHP) in the 1st line therapy for adult patients with diffuse large B-cell lymphoma","authors":"I. Dyakov","doi":"10.17650/1818-8346-2023-18-1-76-87","DOIUrl":"https://doi.org/10.17650/1818-8346-2023-18-1-76-87","url":null,"abstract":"","PeriodicalId":36905,"journal":{"name":"Klinicheskaya Onkogematologiya/Clinical Oncohematology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80638861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment adherence in patients with blood system diseases and recipients of allogeneic organs and tissues 血液系统疾病患者和异体器官和组织受体的治疗依从性
Klinicheskaya Onkogematologiya/Clinical Oncohematology Pub Date : 2023-03-15 DOI: 10.17650/1818-8346-2023-18-1-132-141
E. Kolgaeva, M. Drokov, D. Vybornykh
{"title":"Treatment adherence in patients with blood system diseases and recipients of allogeneic organs and tissues","authors":"E. Kolgaeva, M. Drokov, D. Vybornykh","doi":"10.17650/1818-8346-2023-18-1-132-141","DOIUrl":"https://doi.org/10.17650/1818-8346-2023-18-1-132-141","url":null,"abstract":"","PeriodicalId":36905,"journal":{"name":"Klinicheskaya Onkogematologiya/Clinical Oncohematology","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90248506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Invasive mycoses in patients with hematological malignancies and recipients of hematopoietic stem cell transplantation: results of a systematic review, literature review and meta-analysis 恶性血液病患者和造血干细胞移植受者的侵袭性真菌病:系统综述、文献回顾和荟萃分析的结果
Klinicheskaya Onkogematologiya/Clinical Oncohematology Pub Date : 2023-03-15 DOI: 10.17650/1818-8346-2023-18-1-101-120
M. Popova, Y. Rogacheva
{"title":"Invasive mycoses in patients with hematological malignancies and recipients of hematopoietic stem cell transplantation: results of a systematic review, literature review and meta-analysis","authors":"M. Popova, Y. Rogacheva","doi":"10.17650/1818-8346-2023-18-1-101-120","DOIUrl":"https://doi.org/10.17650/1818-8346-2023-18-1-101-120","url":null,"abstract":"","PeriodicalId":36905,"journal":{"name":"Klinicheskaya Onkogematologiya/Clinical Oncohematology","volume":"47 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76497932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A clinical case of immune-mediated pneumonitis after nivolumab in a patient with Burkitt lymphoma 伯基特淋巴瘤患者纳武单抗后发生免疫介导性肺炎的临床病例
Klinicheskaya Onkogematologiya/Clinical Oncohematology Pub Date : 2023-03-15 DOI: 10.17650/1818-8346-2023-18-1-121-125
K. I. Utesheva, T. Valiev, O. A. Ignatenko, S. V. Goryacheva, N. Batmanova, K. Kirgizov
{"title":"A clinical case of immune-mediated pneumonitis after nivolumab in a patient with Burkitt lymphoma","authors":"K. I. Utesheva, T. Valiev, O. A. Ignatenko, S. V. Goryacheva, N. Batmanova, K. Kirgizov","doi":"10.17650/1818-8346-2023-18-1-121-125","DOIUrl":"https://doi.org/10.17650/1818-8346-2023-18-1-121-125","url":null,"abstract":"","PeriodicalId":36905,"journal":{"name":"Klinicheskaya Onkogematologiya/Clinical Oncohematology","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73068245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
New drug formulations of colony-stimulating factors in oncohematology 肿瘤血液学集落刺激因子的新药物配方
Klinicheskaya Onkogematologiya/Clinical Oncohematology Pub Date : 2023-03-15 DOI: 10.17650/1818-8346-2023-18-1-126-131
T. Valiev, R. R. Fatkhullin, Yu. E. Ryabukhina, P. A. Zeynalova
{"title":"New drug formulations of colony-stimulating factors in oncohematology","authors":"T. Valiev, R. R. Fatkhullin, Yu. E. Ryabukhina, P. A. Zeynalova","doi":"10.17650/1818-8346-2023-18-1-126-131","DOIUrl":"https://doi.org/10.17650/1818-8346-2023-18-1-126-131","url":null,"abstract":"","PeriodicalId":36905,"journal":{"name":"Klinicheskaya Onkogematologiya/Clinical Oncohematology","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74206726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信